Absolute Lymphocyte Count after BCMA CAR-T Therapy is a Predictor of Response and Outcomes in Relapsed Multiple Myeloma.
Mejia Saldarriaga M, Pan D, Unkenholz C, Mouhieddine TH, Velez-Hernandez JE, Engles K, Fein JA, Monge J, Rosenbaum CA, Pearse R, Jayabalan DS, Gordillo CA, Chan HT, Yamshon S, Thibaud S, Mapara MY, Inghirami GG, Lentzsch S, Reshef R, Rossi A, Parekh S, Jagannath S, Richard S, Niesvizky R, Bustoros M.
Mejia Saldarriaga M, et al. Among authors: mapara my.
Blood Adv. 2024 May 22:bloodadvances.2023012470. doi: 10.1182/bloodadvances.2023012470. Online ahead of print.
Blood Adv. 2024.
PMID: 38776397